Jpmorgan Chase & CO Globus Medical Inc Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Globus Medical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,804,330 shares of GMED stock, worth $221 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,804,330
Previous 2,604,774
7.66%
Holding current value
$221 Million
Previous $186 Million
24.47%
% of portfolio
0.02%
Previous 0.02%
Shares
19 transactions
Others Institutions Holding GMED
# of Institutions
537Shares Held
108MCall Options Held
295KPut Options Held
140K-
Vanguard Group Inc Valley Forge, PA10.9MShares$856 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$815 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.61MShares$521 Million0.29% of portfolio
-
State Street Corp Boston, MA3.59MShares$283 Million0.01% of portfolio
-
Burgundy Asset Management Ltd. Toronto, A62.62MShares$206 Million2.26% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $6.07B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...